Stock PSQ PACIFIC SMILES GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Pacific Smiles Group Limited

Equities

PSQ

AU000000PSQ9

Market Closed - Australian S.E.
Other stock markets
 01:56:15 2024-05-01 am EDT 		5-day change 1st Jan Change
1.875 AUD +0.27% Intraday chart for Pacific Smiles Group Limited +14.33% +28.42%
Apr. 29 National Dental Care to Acquire Pacific Smiles Group via Scheme of Arrangement MT
Apr. 29 Australian dental centres operator Pacific Smiles backs $198 mln bid from NDC RE

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The company is in a robust financial situation considering its net cash and margin position.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • The opinion of analysts covering the stock has improved over the past four months.

Weaknesses

  • The company does not generate enough profits, which is an alarming weak point.
  • With an expected P/E ratio at 45.64 and 37.12 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company appears highly valued given the size of its balance sheet.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
PACIFIC SMILES GROUP LIMITED Stock Pacific Smiles Group Limited
+28.42% 194M -
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.25% 85.35B
B-
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+14.46% 81.95B
C+
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+9.37% 28.99B
C+
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-11.40% 16.98B
B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.36% 16.85B
A-
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+0.22% 15.35B
A-
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+4.32% 12.42B
A-
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-2.34% 11.88B
A-
DAVITA INC. Stock DaVita Inc.
+32.69% 12.19B
B-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. PSQ Stock
  4. Ratings Pacific Smiles Group Limited